Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19.
COVID-19
haematology (drugs and medicines)
haematology (incl blood transfusion)
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
24 May 2021
24 May 2021
Historique:
entrez:
25
5
2021
pubmed:
26
5
2021
medline:
28
5
2021
Statut:
epublish
Résumé
We describe the case of a 65-year-old male who presented to an outside hospital for shortness of breath, nausea and vomiting 8 days after testing positive for COVID-19. Initial workup revealed massive bilateral pulmonary emboli and thrombocytopenia. The patient was then admitted to our hospital, received an inferior vena cava filter and initially started on argatroban for autoimmune heparin-induced thrombocytopenia (HIT) prophylaxis. On hospital stay day 6, labs revealed a diagnosis of HIT in the setting of COVID-19. This case highlights the rare occurrence of a patient developing HIT without heparin exposure and in the setting of a novel infectious agent, COVID-19.
Identifiants
pubmed: 34031097
pii: 14/5/e243315
doi: 10.1136/bcr-2021-243315
pmc: PMC8149303
pii:
doi:
Substances chimiques
Anticoagulants
0
Pipecolic Acids
0
Heparin
9005-49-6
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Hematol Rep. 2021 Mar 12;13(1):8857
pubmed: 33747413
Transfus Med Rev. 2006 Oct;20(4):259-72
pubmed: 17008164
Postgrad Med J. 2007 Sep;83(983):575-82
pubmed: 17823223
Clin Chim Acta. 2020 Jul;506:145-148
pubmed: 32178975
Am J Hematol. 2020 Jul 13;:
pubmed: 32658337
Blood Transfus. 2020 May;18(3):167-169
pubmed: 32281926
Brain Behav Immun. 2021 Jul;95:514-517
pubmed: 33857630
N Engl J Med. 2021 Jun 10;384(23):2202-2211
pubmed: 33861525
J Thromb Haemost. 2017 Nov;15(11):2099-2114
pubmed: 28846826
Chest. 2007 Jun;131(6):1644-9
pubmed: 17400685
Hematology Am Soc Hematol Educ Program. 2013;2013:668-74
pubmed: 24319250
Ann Pharmacother. 2021 Feb;55(2):198-215
pubmed: 32693627
Expert Rev Hematol. 2019 Aug;12(8):685-698
pubmed: 31274032
J Am Coll Cardiol. 2016 May 31;67(21):2519-32
pubmed: 27230048
Hematology Am Soc Hematol Educ Program. 2009;:153-8
pubmed: 20008194
WMJ. 2018 Mar;117(1):13-17
pubmed: 29677409
Cardiovasc Drugs Ther. 2021 Apr;35(2):195-203
pubmed: 32870433